Major study aims to predict pain relief in bone cancer patients

NCT ID NCT02356497

Recruiting now Knowledge-focused Sponsor: UMC Utrecht Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 2500 cancer patients with bone metastases to better understand why some respond to radiation therapy and others do not. Researchers will collect data to build tools that predict pain relief and survival, and to create a platform for testing new treatments. The goal is to improve quality of life and personalize care for patients with bone metastases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better prediction tools for pain relief and survival, and faster testing of new treatments for bone metastases.
What could go wrong: This is an observational study, so it does not test a new treatment directly. The prediction tools may not be accurate enough to change clinical practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bone disorder metastatic carcinoma in the bone

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE METASTASES

Contacts and locations

Locations

University Medical Center Utrecht
RECRUITING

Utrecht, Utrecht, 3508 GA, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.